WuXi Diagnostics News and Activities

WuXi Diagnostics is owned by HiberCell. HiberCell has a direct presence in 2 countries.

HiberCell has 7 subsidiaries including Genuity Science, STA Pharmaceutical and WuXi AppTec.

They are in:

• Biotechnology88%
• Pharmaceuticals13%

View the org chart displaying its 4 main executives

Most searched biographies at WuXi Diagnostics

• Chris Chen, Chief Executive Office
• Wesley Guo, Executive Director, Head of Finance
• Liao Minfu, Head, Payment Innovation

Create your alert
to follow the executive moves at WuXi Diagnostics.

HiberCell has 2,413 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Ollin Biosciences has just announced a $330 Million fundraising (posted on June 24 2026).
• RQ Biotechnology has just announced a $86 Million fundraising (posted on June 24 2026).
• Boundless Bio has filed its IPO. Its stock ticker will be AATD. (posted on June 23 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by WuXi Diagnostics

Social media about WuXi Diagnostics

• WuXi Diagnostics on Wikipedia, Google News & Yahoo Finance
• WuXi Diagnostics on LinkedIn, X (Twitter) & YouTube